New York Approves Castle Biosciences Gene Test for Atopic Dermatitis
Castle Biosciences announced it has received assay approval from the New York State Department of Health for its…
Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test
Approval expands access to Castle’s precision medicine test designed to guide systemic treatment decision making in patients with…